VIR
Vir Biotechnology, Inc. · Healthcare
Director George A Scangos sold $307K of Vir Biotechnology, Inc.
Sold$307,259
$11.07Price
27,750Shares
−1%Stake
What VIR did after the filing
- The stock from Mon, Feb 26 close, $11.90
- −19.9%
- S&P 500, same days
- +3.0%
Measured over 30 trading days, to the Apr 9 close.
Traded Thu, Feb 22. Filed Mon, Feb 26, 2:30 PM ET, during the session. Returns use the Feb 26 close and the Apr 9 close. Not investment advice.